Fred Aslan
Director, President and CEO · 1 filing · Latest: Feb 15, 2026
Artiva Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARTV | FRED ASLAN | — | Dec 15, 2025 | Proposed Sale | $3.30 | 12,749 | $42.1K | — | |
ARTV | FRED ASLAN | — | Nov 17, 2025 | Proposed Sale | $3.25 | 6,375 | $20.7K | — | |
ARTV | FRED ASLAN | — | Oct 17, 2025 | Proposed Sale | $2.77 | 25,500 | $70.6K | — | |
ARTV | FRED ASLAN | — | Aug 15, 2025 | Proposed Sale | $2.70 | 25,500 | $68.8K | — |